Literature DB >> 6095406

Selective primary health care: strategies for control of disease in the developing world. XIV. Leishmaniasis.

P D Marsden.   

Abstract

The epidemiology of human leishmaniasis is most complex. Not only are there many species of the parasite in the tropics and subtropics, but each has different sand fly vectors and animal reservoirs and exhibits different behavior in humans. Where epidemiologic information is sufficient, one or more of four methods of control has been effectively used. These are spraying of houses with DDT to control domiciliated phlebotomines (southern Europe, India, Brazil), destruction of animal reservoirs (Brazil, USSR), mass treatment of patients (India, China), and vaccination (USSR, Israel). A drug replacing the pentavalent antimonials as the first-line treatment is a priority, since human infections resistant to currently available drugs occur in many countries and antimonials are difficult to give to outpatients. More research is needed on forest leishmaniasis in the tropical Americas; however, sand fly vectors and animal reservoirs seem inaccessible to control measures. If a vaccine can be developed, it might have great utility. There is an urgent need to map the distribution of predominant species infecting humans in Latin America, since treatment schedules differ for the various cutaneous infections.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095406     DOI: 10.1093/clinids/6.5.736

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

1.  Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes.

Authors:  M E Wilson; R D Pearson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

2.  Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis.

Authors:  A Barral; M Barral-Netto; E C Yong; C E Brownell; D R Twardzik; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

3.  Visceral leishmaniasis: rapid response to AmBisome treatment.

Authors:  O P Smith; I M Hann; H Cox; V Novelli
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

4.  Short term treatment of visceral leishmaniasis of the Old World with low dose interferon gamma and pentavalent antimony.

Authors:  J van Lunzen; P Kern; J Schmitz; J Brzoska; S Flessenkämper; M Dietrich
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

5.  Immune complex antigens as a tool in serodiagnosis of kala-azar.

Authors:  Tapati Chakraborti; Dwijen Sarkar; Dilip K Ghosh
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.